Bausch & Lomb Incorporated

🇺🇸United States
Ownership
-
Established
1992-10-08
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Tear Evaluation Between Habitual Contact Lens Wearers and Non Contact Lens Wearers

First Posted Date
2011-03-17
Last Posted Date
2020-01-09
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
25
Registration Number
NCT01317030
Locations
🇺🇸

Bausch & Lomb Incorporated, Rochester, New York, United States

A Study to Evaluate a New Silicone Hydrogel Contact Lens

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Investigational Lens
Device: Air Optix Aqua lens
First Posted Date
2011-03-07
Last Posted Date
2014-11-24
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
66
Registration Number
NCT01309893
Locations
🇺🇸

Bausch & Lomb, Rochester, New York, United States

Evaluation of a New Silicone Hydrogel Contact Lens

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Air Optix Aqua
Device: Test lens
First Posted Date
2011-03-07
Last Posted Date
2015-02-23
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
66
Registration Number
NCT01309880
Locations
🇺🇸

Bausch & Lomb, Incorporated, Rochester, New York, United States

Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Investigational lens
Device: Air Optix Aqua lens
First Posted Date
2011-03-07
Last Posted Date
2020-10-22
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
66
Registration Number
NCT01309906
Locations
🇺🇸

Bausch & Lomb Incorporated, Rochester, New York, United States

A Study to Evaluate the Performance of Two Designs of Soft Toric Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: PureVision Toric Lens
Device: Investigational Toric Lens
First Posted Date
2011-03-07
Last Posted Date
2020-10-08
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
302
Registration Number
NCT01309867
Locations
🇺🇸

Bausch & Lomb, Rochester, New York, United States

Product Feasibility of a New Silicone Hydrogel Contact Lens

First Posted Date
2011-03-04
Last Posted Date
2014-04-29
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
144
Registration Number
NCT01309100
Locations
🇺🇸

Bausch & Lomb Incorporated, Rochester, New York, United States

Evaluation of Two Daily Disposable Contact Lenses.

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Experimental- Soflens
Device: Marketed - Soflens
First Posted Date
2011-02-21
Last Posted Date
2020-10-06
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
441
Registration Number
NCT01300065
Locations
🇺🇸

Bausch & Lomb Incorporated, Rochester, New York, United States

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Phase 3
Terminated
Conditions
Inflammation
Pain
Cataract
Interventions
Drug: Mapracorat
Drug: Vehicle
First Posted Date
2011-02-18
Last Posted Date
2020-09-03
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
177
Registration Number
NCT01298752
Locations
🇺🇸

Bausch & Lomb Incorporated, Rochester, New York, United States

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Phase 2
Completed
Conditions
Conjunctivitis, Allergic
Interventions
Drug: Mapracorat
Drug: Vehicle
First Posted Date
2011-02-03
Last Posted Date
2020-09-04
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
236
Registration Number
NCT01289431
Locations
🇺🇸

Bausch & Lomb, Rochester, New York, United States

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

First Posted Date
2011-01-14
Last Posted Date
2020-10-05
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
601
Registration Number
NCT01277341
Locations
🇺🇸

ISTA Pharmaceuticals, Inc., Irvine, California, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy